Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus

Virology

Volumn 404, Issue 1, 2010, Pages 32-40

  Zhu, James ^a   Weiss, Marcelo ^a,b   Grubman, Marvin J ^a   Santos, Teresa de los ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

FMDV; Microarray; NF B; Picornaviruses

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CXCL3 CHEMOKINE; FRACTALKINE; GENERAL TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 4E; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 28; LEADER PROTEINASE; MYXOVIRUS RESISTANCE PROTEIN; PROTEIN NOXA; PROTEINASE; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRISTETRAPROLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COW; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; INNATE IMMUNITY; LEADERLESS FOOT AND MOUTH DISEASE VIRUS; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; UPREGULATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CATTLE; CELLS, CULTURED; ENDOPEPTIDASES; FOOT-AND-MOUTH DISEASE VIRUS; GENE DELETION; GENE EXPRESSION PROFILING; IMMUNE EVASION; IMMUNITY, INNATE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VIRULENCE FACTORS;

BOVINAE; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 77953808439     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.04.021     Document Type: Article

References (79)

1. Amé J.-C., Spenlehauer C., de Murcia G. The PARP superfamily. Bioassays 2004, 8:882-893.
2. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R. Lambda interferon (IFN-Λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 2006, 80:4501-4509.
3. Babbar N., Hacker A., Huang Y., Casero R.A. Tumor necrosis factor alpha induces spermidine/spermine N1-acetyltransferase through nuclear factor kappa B in non-small cell lung cancer cells. J. Biol. Chem. 2006, 281:24182-24192.
4. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
5. Brown C.C., Piccone M.E., Mason P.W., McKenna T.S., Grubman M.J. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol. 1996, 70:5638-5641.
6. Carr M.W., Roth S.J., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl Acad. Sci. USA 1994, 91:3652-3656.
7. Chin K.C., Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl Acad. Sci. USA 2001, 98:15125-15130.
8. Chinsangaram J., Mason P.W., Grubman M.J. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 1998, 16:1516-1522.
9. Chinsangaram J., Koster M., Grubman M.J. Inhibition of L-deleted foot- and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 2001, 75:5498-5503.
10. Chinsangaram J., Piccone M.E., Grubman M.J. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 1999, 73:9891-9898.
11. Chowdhury D., Beresford P.J., Zhu P., Zhang D., Sung J.S., Demple B., Perrino F.W., Lieberman J. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol. Cell. 2006, 23:133-142.
12. de los Santos T., de Avila Botton S., Weiblen R., Grubman M.J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 2006, 80:1906-1914.
13. de los Santos T., Diaz-San Segundo F., Grubman M.J. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 2007, 81.
14. de los Santos T., Diaz-San Segundo F., Zhu J., Koster M., Dias C.C., Grubman M.J. conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J. Virol. 2009, 83:1800-1810.
15. Der S.D., Zhou A., Williams B.R.G., Silverman R.H. Identification of genesdifferentially regulated by interferon α, β or γ using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 1998, 95:15623-15628.
16. Devaney M.A., Vakharia V.N., Lloyd R.E., Ehrenfeld E., Grubman M.J. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 1988, 62:4407-4409.
17. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., Silverman R.H., Williams B.R.G. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 2001, 69:912-920.
18. Diaz-San Segundo F., Moraes M.P., de los Santos T., Dias C.C.A., Grubman M.J. Interferon-induced protection against foot-and-mouth disease virus correlates with enhanced tissue specific innate immune cell infiltration and interferon stimulated gene expression. J. Virol. 2010, 84:2063-2077.
19. Díaz-San Segundo F., Salguero F.J., de Avila A., de Marco M.M., Sánchez-Martín M.A., Sevilla N. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J. Virol. 2006, 80:2369-2379.
20. Franchini C., Fontana F., Minuzzo M., Babbio F., Privitera E. Apoptosis promoted by up-regulation of TFPT (TCF3 fusion partner) appears p53 independent, cell type restricted and cell density influenced. Apoptosis 2006, 12:2217-2224.
21. Gao G., Guo X., Goff S.P. CCCH-type zinc finger protein inhibition. Science 2002, 297:1703-1716.
22. Geiser T., Dewald B., Ehrengruber M.U., Clark-Lewis I., Baggiolini M. The interleukin-8-related chemotactic cytokines GROa, GROB, and GROT activate human neutrophil and basophil leukocytes. J. Biol. Chem. 1993, 268. 15419-15424 Gilmore T.D. 2008. www.NF-kB.org.
23. Ghosh S.K., Kusari J., Bandyopadhyay S.K., Samanta H., Kumar R., Sen G.C. Cloning, sequencing, and expression of two murine 2-5'-oligoadenylate synthetases: structure-function relationships. J. Biol. Chem. 1991, 266:15293-15299.
24. Grubman M.J., Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17:465-493.
25. Guenzi E., Töpolt K., Cornali E., Lubeseder-Martellato C., Jörg A., Matzen K., Zietz C., Kremmer E., Nappi F., Schwemmle M., Hohenadl C., Barillari G., Tschachler E., Monini P., Ensoli B., Stürzl M. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 2001, 20:5568-5577.
26. Haas A.L., Ahrens P., Bright P.M., Ankel H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 1987, 262:11315-11323.
27. Halees A.S., Leyfer D., Weng Z. PromoSer: A large-scale mammalian promoter and transcription start site identification service. Nucleic Acids Res. 2003, 31:3554-3559.
28. Haller O., Staeheli P., Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 2007, 89:812-818.
29. Haskill S., Beg A.A., Tompkins S.M., Morris J.S., Yurochko A.D., Sampson Johannes A., Mondal K., Ralph P., Baldwin A.S. Characterization of an immediate-early gene induced in adherent monocytes that encodes IΚB-like activity. Cell 1991, 65:1281-1299.
30. Haverty P.M., Frith M.C., Weng Z. CARRIE web service: automated transcriptional regulatory network inference and interactive analysis. Nucleic Acids Res. 2004, 32. Web Server issue), W213-6.
31. Hayden M.S., West A.P., Ghosh S. NF-ΚB and the immune response. Oncogene 2006, 25:6758-676780.
32. Hayden M.S., Ghosh S. Shared principles in NF-κB signaling. Cell 2008, 132:344-362.
33. Huang X., Madan A. CAP3: A DNA sequence assembly program. Genome Res. 1999, 9:868-877.
34. Honda K., Yanai H., Takaoka A., Taniguchi T. Regulation of the type I IFN induction: a current view. Int. Immunol. 2006, 17:1367-1378.
35. Jin J., Cardozo T., Lovering R.C., Elledge S.J., Pagano M., Harper J.W. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 2004, 18:2573-2580.
36. Jin H., Xiao C., Zhao G., Du X., Yu Y., Kang Y., Wang B. Induction of immature dendritic cell apoptosis by foot and mouth disease virus is an integrin receptor mediated event before viral infection. J. Cell. Biochem. 2007, 102:980-991.
37. Karolchik D., Baertsch R., Diekhans M., Furey T.S., Hinrichs A., Lu Y.T., Roskin K.M., Schwartz M., Sugnet C.W., Thomas D.J., Weber R.J., Haussler D., Kent W.J. The UCSC genome browser database. Nucleic Acids Res. 2003, 31:51-54.
38. Kirchweger R., Ziegler E., Lamphear B.J., Waters D., Liebig H.D., Sommergruber W., Sobrino F., Hohenadl C., Blaas D., Rhoads R.E., Skern T. Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J. Virol. 1994, 68:5677-5684.
39. Kitareewan S., Pitha-Rowe I., Sekula D., Lowrey C.H., Nemeth M.J., Golub T.R., Freemantle S.J., Dmitrovsky E. UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA 2002, 99:3806-3811.
40. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4:69-76.
41. Lai W.S., Kennington E.A., Blackshear P.J. Interactions of CCCH-zinc finger proteins with mRNA. J. Biol. Chem. 2002, 27:9606-9613.
42. Leek J.T., Monsen E., Dabney A.R., Storey J.D. EDGE: extraction and analysis of differential gene expression. Bioinformatics 2006, 22:507-508.
43. Lenschow D.J., Lai C., Frias-Staheli N., Giannakopoulos N.V., Lutz A., Wolff T., Osiak A., Levine B., Schmidt R.E., García-Sastre A., Leib D.A., Pekosz A., Knobeloch K.P., Horak I., Virgin 4th H.W. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes and Sindbis viruses. Proc. Natl Acad. Sci. USA 2007, 104:1371-1376.
44. Li F.Y., Nikali K., Gregan J., Leibiger I., Leibiger B., Schweyen R., Larsson C., Suomalainen A. Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4. FEBS Lett. 2001, 494:79-84.
45. Loeb K.R., Haas A.L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 1992, 267:7806-7813.
46. Lu D., Chen J., Hai T. he regulation of ATF3 gene expression by mitogen activated protein kinases. Biochem. J. 2007, 401:559-567.
47. Malakhov M.P., Malakhova O.A., Kim K.I., Ritchie K.J., Zhang D.-E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 2002, 277:9976-9981.
48. Mason P.W., Piccone M.E., McKenna T.S., Chinsangaram J., Grubman M.J. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997, 227:96-102.
49. Mason P.W., Grubman M.J., Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 2003, 91:9-32.
50. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
51. Onoguchi K., Yoneyama M., Takemura A., Akira S., Taniguchi T., Namiki H., Fujita T. Viral infections activate Types I and III Interferon genes through a common mechanism. J. Biol. Chem. 2007, 282:7576-7581.
52. Osterlund P.I., Pietila T.E., Veckman V., Kotenko S.V., Julkunen I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFNlambda) genes. J. Immunol. 2007, 179:3434-3442.
53. Padovan E., Terracciano L., Certa U., Jacobs B., Reschner A., Bolli M., Spagnoli G.C., Borden E.C., Heberer M. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res. 2002, 62:3453-3458.
54. Peng J.M., Liang S.M., C.M.Liang VP1 of foot-and-mouth disease virus induces apoptosis via the Akt signaling pathway. J. Biol. Chem. 2004, 279:52168-52174.
55. Perrino F.W., Miller H., Ealey K.A. Identification of a 3'→5'-exonuclease that removes cytosine arabinoside monophosphate from 3' termini of DNA. J. Biol. Chem. 1994, 269:16357-16363.
56. Piccone M.E., Rieder E., Mason P.W., Grubman M.J. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 1995, 69:5376-5382.
57. Prêle C.M., Woodward E.A., Bisley J., Keith-Magee A., Nicholson S.E., Hart P.H. SOCS1 regulates the IFN but not NFB pathway in TLR-stimulated human monocytes and macrophages. J. Immunol. 2008, 181:8018-8026.
58. Reese M.G. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput. Chem. 2001, 26:51-56. HYPERLINK http://www.fruitfly.org/~martinr/index.html.
59. Reines D., Conaway J.W., Conaway R.C. The RNA polymerase II general elongation factors. Trends Biochem. Sci. 1996, 21:351-355.
60. Rieder E., Bunch T., Brown F., Mason P.W. Genetically engineered foot-and mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 1993, 67:5139-5145.
61. Ryan M.D., King A.M., Thomas G.P. Cleavage of foot-and mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 1991, 72:2727-2732.
62. Rychlik W., Domier L.L., Gardner P.R., Hellmann G.M., Rhoads R.E. Amino acid sequence of the mRNA cap-binding protein from human tissues. Proc. Natl Acad. Sci. USA 1987, 84:945-949.
63. Salomonis N., Hanspers K., Zambon A.C., Vranizan K., Lawlor S.C., Dahlquist K.D., Doniger S.W., Stuart J., Conklin B.R., Pico A.R. GenMAPP 2: new features and resources for pathway analysis. BMC Bioinform. 2007, 8:217-229.
64. Sharf R., Azriel A., Lejbkowicz F., Winograd S.S., Ehrlich R., Levi B.Z. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 1995, 270:13063-13069.
65. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4:63-68.
66. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
67. Strausberg R.L., et al. Mammalian Gene Collection (MGC) Program Team. Proc. Natl Acad. Sci. USA 2002, 99:16899-16903.
68. Strebel K., Beck E. A second protease of foot-and-mouth disease virus. J. Virol. 1986, 58:893-899.
69. Sugimoto M., Nakamura T., Ohtani N., Hampson L., Hampson I.N., Shimamoto A., Furuichi Y., Okumura K., Niwa S., Taya Y., Hara E. Regulation of CDK4 activity by a novel CDK4-binding protein, p34 (SEI-1). Genes Dev. 1999, 13:3027-3033.
70. Tahara E., Tahara H., Kanno M., Naka K., Takeda Y., Matsuzaki T., Yamazaki R., Ishihara H., Yasui W., Barrett J.C., Ide T., Tahara E. G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell. Cancer Immunol. Immunother. 2005, 54:729-740.
71. Takeyama K., Aguiar R.C., Gu L., He C., Freeman G.J., Kutok J.L., Aster J.C., Shipp M.A. The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity. J. Biol. Chem. 2003, 278:21930-21937.
72. Terenzi F., Hui D.J., Merrick W.C., Sen G.C. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 2006, 281:34064-34071.
73. Thanos D., Maniatis T. Virus induction of human IFN-Β gene expression requires the assembly of an enhanceosome. Cell 1995, 83:1091-1100.
74. Veals S.A., Schindler C., Leonard D., Fu X.Y., Aebersold R., Darnell J.E., Levy D.E. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 1992, 12:3315-3324.
75. Verghese G.M., Johnson J.D., Vasulka C., Haupt D.M., Stumpo D.J., Blackshear P.J. Protein kinase C-mediated phosphorylation and calmodulin binding of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein. J. Biol. Chem. 1994, 269:9361-9367.
76. Wu M.X. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 2003, 8:11-18.
77. Yamashita M., Katsumata M., Iwashima M., Kimura M., Shimizu C., Kamata T., Shin T., Seki N., Suzuki S., Taniguchi M., Nakayama T. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. J. Exp. Med. 2000, 191:1869-1879.
78. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.-M., Gale M., Akira S., Yonehara S., Kato A., Fujita T. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 2005, 175:2851-2858.
79. Zheng J., Wu J., Sun Z. An approach to identify over-represented cis-elements in related sequences. Nucleic Acids Res. 2003, 31:1995-2005.